TrialNature medicine2022

Safety and immunogenicity of a ferritin nanoparticle H2 influenza vaccine in healthy adults: a phase 1 trial.

Katherine V Houser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.